{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T20:34:19Z","timestamp":1759178059811,"version":"3.37.3"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2015,7,31]],"date-time":"2015-07-31T00:00:00Z","timestamp":1438300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1007\/s00228-015-1911-2","type":"journal-article","created":{"date-parts":[[2015,7,30]],"date-time":"2015-07-30T03:18:03Z","timestamp":1438226283000},"page":"1263-1270","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Income differences in the type of antihypertensive medicines used in ambulatory settings in Finland: a register-based study"],"prefix":"10.1007","volume":"71","author":[{"given":"H\u00e4rk\u00f6nen","family":"Mirva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timonen","family":"Johanna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tervola","family":"Jussi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katri","family":"Aaltonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,7,31]]},"reference":[{"issue":"9859","key":"1911_CR1","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1016\/S0140-6736(12)61766-8","volume":"380","author":"SS Lim","year":"2012","unstructured":"Lim SS, Vos T, Flaxman AD et al (2012) A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380(9859):2224\u20132260","journal-title":"Lancet"},{"issue":"5","key":"1911_CR2","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2013.284427","volume":"311","author":"PA James","year":"2014","unstructured":"James PA, Oparil S, Carter BL et al (2014) 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 311(5):507\u2013520","journal-title":"JAMA"},{"key":"1911_CR3","first-page":"169","volume-title":"Health inequalities in Finland. Trends in socioeconomic health differences 1980\u20132005","author":"A Reunanen","year":"2009","unstructured":"Reunanen A, Kattainen A, Salomaa V (2009) Biological risk factors. In: Palosuo H et al (eds) Health inequalities in Finland. Trends in socioeconomic health differences 1980\u20132005. Publications of the Ministry of Social Affairs and Health 9, Helsinki, pp 169\u2013177"},{"key":"1911_CR4","unstructured":"Statistics Finland (2011) Causes of death http:\/\/tilastokeskus.fi\/til\/ksyyt\/2011\/ksyyt_2011_2012-12-21_tie_001_en.html . Accessed 11 March 2014"},{"key":"1911_CR5","first-page":"40","volume-title":"Health inequalities in Finland. Trends in socioeconomic health differences 1980\u20132005","author":"T Valkonen","year":"2009","unstructured":"Valkonen T, Ahonen H, Martikainen P et al (2009) Socio-economic differences in mortality. In: Palosuo H et al (eds) Health inequalities in Finland. Trends in socioeconomic health differences 1980\u20132005. Publications of the Ministry of Social Affairs and Health 9, Helsinki, pp 40\u201360"},{"key":"1911_CR6","author":"K Manderbacka","year":"2008","unstructured":"Manderbacka K, Keskim\u00e4ki I, Reunanen A et al (2008) Equity in the use of antithrombotic drugs, beta-blockers and statins among Finnish coronary patients. Int J Equity Health. doi: 10.1186\/1475-9276-7-16","journal-title":"Int J Equity Health"},{"key":"1911_CR7","author":"T Vehko","year":"2013","unstructured":"Vehko T, Sund R, Arffman M et al (2013) Monitoring the use of lipid-lowering medication among persons with newly diagnosed diabetes: a nationwide register-based study. BMJ Open. doi: 10.1136\/bmjopen-2013-003414","journal-title":"BMJ Open"},{"key":"1911_CR8","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1034\/j.1600-0579.2003.00211.x","volume":"51","author":"AF Brown","year":"2003","unstructured":"Brown AF, Gross AG, Gutierrez PR et al (2003) Income-related differences in the use of evidence-based therapies in older persons with diabetes mellitus in for-profit managed care. J Am Geriatr Soc 51:665\u2013670","journal-title":"J Am Geriatr Soc"},{"issue":"5","key":"1911_CR9","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/j.1365-2125.2005.02494.x","volume":"60","author":"RW Thomsen","year":"2005","unstructured":"Thomsen RW, Johnsen SP, Olesen AV et al (2005) Socioeconomic gradient in use of statins among Danish patients: population-based cross-sectional study. Br J Clin Pharmacol 60(5):534\u2013542","journal-title":"Br J Clin Pharmacol"},{"key":"1911_CR10","doi-asserted-by":"crossref","first-page":"152","DOI":"10.2174\/1874192400903010152","volume":"3","author":"H Dominguez","year":"2009","unstructured":"Dominguez H, Schramm TK, Norgaard ML et al (2009) Initiation and persistence to statin treatment in patients with diabetes receiving glucose-lowering medications 1997\u20132006. Open Cardiovasc Med J 3:152\u2013159","journal-title":"Open Cardiovasc Med J"},{"issue":"3","key":"1911_CR11","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1365-2125.2008.03360.x","volume":"67","author":"R Selmer","year":"2009","unstructured":"Selmer R, Sakshaug S, Skurtveit S et al (2009) Statin treatment in a cohort of 20 212 men and women in Norway according to cardiovascular risk factors and level of education. Br J Clin Pharmacol 67(3):355\u2013362","journal-title":"Br J Clin Pharmacol"},{"key":"1911_CR12","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1136\/jech.55.7.475","volume":"55","author":"V Salomaa","year":"2001","unstructured":"Salomaa V, Miettinen H, Niemel\u00e4 M et al (2001) Relation of socioeconomic position to the case fatality, prognosis and treatment of myocardial infarction events; the FINMONICA MI Register Study. J Epidemiol Community Health 55:475\u2013482","journal-title":"J Epidemiol Community Health"},{"key":"1911_CR13","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1177\/1403494810364558","volume":"38","author":"T Vehko","year":"2010","unstructured":"Vehko T, Manderbacka K, Arffman M et al (2010) Changing patterns of secondary preventive medication among newly diagnosed coronary heart disease patients with diabetes in Finland: a register-based study. Scand J Public Health 38:317\u2013324","journal-title":"Scand J Public Health"},{"key":"1911_CR14","unstructured":"Working group appointed by the Finnish Medical Society Duodecim and the Finnish Hypertension Society (2009, updated version in 2014) Current Care Guideline: Hypertension. Duodecim, Helsinki"},{"key":"1911_CR15","unstructured":"National Clinical Guideline Centre commissioned by the National Institute for Health and Clinical Excellence (2011) Hypertension. The clinical management of primary hypertension in adults. Clinical Guideline 127. National Clinical Guideline Centre, London"},{"issue":"7","key":"1911_CR16","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1097\/01.hjh.0000431740.32696.cc","volume":"31","author":"G Mancia","year":"2013","unstructured":"Mancia G, Fagard R, Narkiewicz K et al (2013) 2013 ESH\/ESC Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 31(7):1281\u20131357","journal-title":"J Hypertens"},{"issue":"4","key":"1911_CR17","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1177\/1741826711410835","volume":"19","author":"TL Ahola","year":"2012","unstructured":"Ahola TL, Kantola IM, M\u00e4ki J et al (2012) Adding a low-dose antihypertensive regimen would substantially improve the control of hypertension and reduce cardiovascular morbidity among uncomplicated hypertensive patients. Eur J Prev Cardiol 19(4):712\u2013722","journal-title":"Eur J Prev Cardiol"},{"issue":"8","key":"1911_CR18","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1097\/00005650-200308000-00004","volume":"41","author":"R Tamblyn","year":"2003","unstructured":"Tamblyn R, McLeod P, Hanley JA et al (2003) Physician and practice characteristics associated with the early utilization of new prescription drugs. Med Care 41(8):895\u2013908","journal-title":"Med Care"},{"issue":"4","key":"1911_CR19","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1080\/02813430701652036","volume":"25","author":"A Buusman","year":"2007","unstructured":"Buusman A, Andersen M, Merrild C et al (2007) Factors influencing GPs\u2019 choice between drugs in a therapeutic drug group. A qualitative study. Scand J Prim Health Care 25(4):208\u2013213","journal-title":"Scand J Prim Health Care"},{"key":"1911_CR20","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1007\/s00228-008-0549-8","volume":"64","author":"SI Haider","year":"2008","unstructured":"Haider SI, Johnell K, Ringb\u00e4ck Weitoft G et al (2008) Patient educational level and use of newly marketed drugs: a register-based study of over 600,000 older people. Eur J Clin Pharmacol 64:1215\u20131222","journal-title":"Eur J Clin Pharmacol"},{"key":"1911_CR21","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00228-008-0569-4","volume":"65","author":"H Ohlsson","year":"2009","unstructured":"Ohlsson H, Chaix B, Merlo J (2009) Therapeutic traditions, patient socioeconomic characteristics and physicians\u2019 early new drug prescribing\u2014a multilevel analysis of rosuvastatin prescription in south Sweden. Eur J Clin Pharmacol 65:141\u2013150","journal-title":"Eur J Clin Pharmacol"},{"issue":"8","key":"1911_CR22","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1136\/jech.2008.081166","volume":"64","author":"H Ohlsson","year":"2010","unstructured":"Ohlsson H, Lynch K, Merlo J (2010) Is the physician\u2019s adherence to prescription guidelines associated with the patient\u2019s socio-economic position? An analysis of statin prescription in south Sweden. J Epidemiol Community Health 64(8):678\u2013683","journal-title":"J Epidemiol Community Health"},{"key":"1911_CR23","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/pds.3402","volume":"22","author":"B Semark","year":"2013","unstructured":"Semark B, Engstr\u00f6m S, Brudin L et al (2013) Factors influencing the prescription of drugs of different price levels. Pharmacoepidemiol Drug Saf 22:286\u2013293","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1911_CR24","doi-asserted-by":"crossref","unstructured":"OECD (2011) Health at a glance 2011: OECD Publishing. http:\/\/dx.doi.org\/ 10.1787\/health_glance-2011-63-en . Accessed 1 November 2013","DOI":"10.1787\/health_glance-2011-63-en"},{"key":"1911_CR25","unstructured":"Mossialos E, Srivastava D. (2008) Pharmaceutical policies in Finland. Challenges and opportunities. Observatory studies series 10. European Observatory on Health Systems and Policies. http:\/\/www.euro.who.int\/__data\/assets\/pdf_file\/0020\/80651\/E91239.pdf"},{"key":"1911_CR26","volume-title":"OECD reviews of health systems","author":"Organisation for Economic Co-Operation and Development","year":"2005","unstructured":"Organisation for Economic Co-Operation and Development (2005) OECD reviews of health systems. OECD, Paris, Finland"},{"key":"1911_CR27","unstructured":"Blomgren J, Aaltonen K, Tervola J et al. (2015) Kelan sairaanhoitokorvaukset tuloryhmitt\u00e4in: kenelle korvauksia maksetaan ja kuinka paljon? (Finnish: National Health Insurance (NHI) reimbursements by income group) Sosiaali- ja terveysturvan selosteita 93. Kelan tutkimusosasto, Helsinki. http:\/\/hdl.handle.net\/10138\/154606"},{"issue":"3","key":"1911_CR28","first-page":"199","volume":"28","author":"LK Saastamoinen","year":"2012","unstructured":"Saastamoinen LK, Aaltonen K, Maljanen T et al (2012) Health registers as a source of data for research and policy making. Dosis 28(3):199\u2013205","journal-title":"Dosis"},{"key":"1911_CR29","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1742-7843.2009.00494.x","volume":"106","author":"K Furu","year":"2010","unstructured":"Furu K, Wettermark B, Andersen M et al (2010) The Nordic countries as a cohort for pharmacoepidemiological research. Basic Clin Pharmacol Toxicol 106:86\u201394","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"1911_CR30","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology (2013) ATC\/DDD Index 2013 http:\/\/www.whocc.no\/atcddd\/ . Accessed 11 September 2013"},{"key":"1911_CR31","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology (2014) Guidelines for ATC classification and DDD assignment 2015 Oslo"},{"issue":"4","key":"1911_CR32","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1080\/00031305.1980.10483031","volume":"34","author":"SR Searle","year":"1980","unstructured":"Searle SR, Speed FM, Milliken GA (1980) Population marginal means in the linear model: an alternative to least squares means. Am Stat 34(4):216\u2013221","journal-title":"Am Stat"},{"key":"1911_CR33","volume-title":"Adherence to long-term therapies: evidence for action","author":"E Sabat\u00e9","year":"2003","unstructured":"Sabat\u00e9 E (2003) Adherence to long-term therapies: evidence for action. WHO\/MNC\/03.01, World Health Organization, Geneva"},{"key":"1911_CR34","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2147\/PPA.S55382","volume":"8","author":"M Lemstra","year":"2014","unstructured":"Lemstra M, Alsabbagh MW (2014) Proportion and risk indicators of nonadherence to antihypertensive therapy: a meta-analysis. Pat Pref Adhere 8:211\u2013218","journal-title":"Pat Pref Adhere"},{"issue":"3","key":"1911_CR35","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/eurpub\/cku176","volume":"25","author":"K Aaltonen","year":"2015","unstructured":"Aaltonen K, Miettinen J, Airio I, Martikainen JE, Saastamoinen LK, Bell JS, Hartikainen S, Norris P (2015) Cost-related barriers to use of health services and prescription medicines in Finland: a cross-sectional survey. Eur J Public Health 25(3):368\u2013372","journal-title":"Eur J Public Health"},{"key":"1911_CR36","unstructured":"Social Insurance Institution of Finland. Statistical database Kelasto. http:\/\/www.kela.fi\/kelasto Accessed 17 September 2014"},{"key":"1911_CR37","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/pds.1635","volume":"17","author":"G Ringb\u00e4ck Weitoft","year":"2008","unstructured":"Ringb\u00e4ck Weitoft G, Ros\u00e9n M, Ericsson \u00d6 et al (2008) Education and drug use in Sweden\u2014a nationwide register-based study. Pharmacoepidemiol Drug Saf 17:1020\u20131028","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1911_CR38","unstructured":"Merlo J, Ohlsson H, Carlsson M (2009) T\u00e5l inte rika sk\u00e5ningar ACE-h\u00e4mmare? https:\/\/www.skane.se\/upload\/Webbplatser\/UMAS\/VERKSAMHETER%20UMAS\/Socialmedicin\/08-l%C3%A4kemedel\/tal-inte-rika-skaningar-ace.pdf"},{"issue":"11","key":"1911_CR39","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1016\/j.socscimed.2006.07.019","volume":"63","author":"JP Greving","year":"2006","unstructured":"Greving JP, Denig P, van der Veen WJ et al (2006) Determinants for the adoption of angiotensin II receptor blockers by general practitioners. Soc Sci Med 63(11):2890\u20132898","journal-title":"Soc Sci Med"},{"issue":"1","key":"1911_CR40","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s002280100271","volume":"57","author":"A H\u00e5kansson","year":"2001","unstructured":"H\u00e5kansson A, Andersson H, Cars H et al (2001) Prescribing, prescription costs and adherence to formulary committee recommendations: long-term differences between physicians in public and private care. Eur J Clin Pharmacol 57(1):65\u201370","journal-title":"Eur J Clin Pharmacol"},{"key":"1911_CR41","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/02813430902793225","volume":"27","author":"K Andersson","year":"2009","unstructured":"Andersson K, Carlsten A, Hedenrud T (2009) Prescribing behaviour after the introduction of decentralized drug budgets: is there an association with employer and type of care facility? Scand J Prim Health Care 27:117\u2013122","journal-title":"Scand J Prim Health Care"},{"issue":"2","key":"1911_CR42","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1503\/cmaj.050584","volume":"174","author":"E Doorslaer van","year":"2006","unstructured":"van Doorslaer E, Masseria C, Koolman X, for the OECD Health Equity Research Group (2006) Inequalities in access to medical care by income in developed countries. CMAJ 174(2):177\u2013183","journal-title":"CMAJ"},{"issue":"2","key":"1911_CR43","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/eurpub\/ckt141","volume":"24","author":"AH Entonen","year":"2014","unstructured":"Entonen AH, Suominen SB, Korkeila K et al (2014) Migraine predicts hypertension\u2014a cohort study of the Finnish working-age population. Eur J Public Health 24(2):244\u2013248","journal-title":"Eur J Public Health"},{"key":"1911_CR44","first-page":"66","volume-title":"Health, functional capacity and welfare in Finland in 2011","author":"A Jula","year":"2012","unstructured":"Jula A, Salomaa V, Aromaa A et al (2012) Verenpaine (Finnish: hypertension). In: Koskinen S et al (eds) Health, functional capacity and welfare in Finland in 2011. National Institute for Health and Welfare (THL), Report 68, Helsinki, pp 66\u201369"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-015-1911-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-015-1911-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-015-1911-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T07:56:41Z","timestamp":1718006201000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-015-1911-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,31]]},"references-count":44,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["1911"],"URL":"https:\/\/doi.org\/10.1007\/s00228-015-1911-2","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"type":"print","value":"0031-6970"},{"type":"electronic","value":"1432-1041"}],"subject":[],"published":{"date-parts":[[2015,7,31]]}}}